Physician profile
Tyler Downing
NPI 1407380611
$711.32
in general payments reported to CMS, 2019-2025
10 companies · $502 in 2025
The $502 reported for 2025 was more than what 79% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $209 · 2025: $502.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $711.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $711.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $248.38 | 2024-2025 | |
| Genzyme Corporation | $92.21 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $77.74 | 2025 | Spevigo |
| Novartis Pharmaceuticals Corporation | $74.81 | 2025 | |
| Krystal Biotech INC | $54.27 | 2025 | Vyjuvek |
| Galderma Laboratories, L.P. | $50.00 | 2025 | |
| Arcutis Biotherapeutics, INC. | $43.22 | 2025 | Zoryve |
| E.R. Squibb & Sons, L.L.C. | $29.05 | 2025 | Sotyktu |
| Leo Pharma INC. | $23.44 | 2025 | Adbry |
| Janssen Biotech, INC. | $18.20 | 2025 | Tremfya |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tyler Downing listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.